Multiple Myeloma Treatment: What’s New?

srcs:

cancer,gov: “stopping multiple myeloma with new treatments”

cancer.gov…: “pomalidomide for multiple myeloma”

cancer.gov…: “drugs approved for multiple myeloma”

cancer.gov…: “new use for lenalidomide in multiple myeloma”

hans c. lee, md, university of texas md anderson cancer center.

blood: “safety and efficacy of selinexor in relapsed or refractory multiple myeloma and waldenstrom macroglobulinemia.”

fda: “fda grants accelerated approval to selinexor for multiple myeloma.”

mayo clinic: “monoclonal antibody drugs for cancer: how they work.”

drugs: “elotuzumab: a review in relapsed and/or refractory multiple myeloma.”

the new england journal of med: “elotuzumab + pomalidomide and dexamethasone for multiple myeloma.”

national cancer institute: “fda approves new use for daratumumab in multiple myeloma,” “fda approves panobinostat for some patients with multiple myeloma.”

international myeloma foundation: “darzalex (daratumumab),” “ninlaro (ixazomib),” “belantamab mafodotin anti-bcma adc.”

multiple myeloma research foundation: “standard treatments.”

frontiers in immunology: “therapeutic bi-specific t-cell engager antibody targeting the transferrin receptor.”

original content at: www.webmd.com…
authors:

Share:

Leave a Reply

Your email address will not be published. Required fields are marked *